1![Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio](https://www.pdfsearch.io/img/a6f9c91d983d5618b81398f5d2de9336.jpg) | Add to Reading ListSource URL: www.pmda.go.jpLanguage: English - Date: 2016-08-04 23:26:09
|
---|
2![SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv](https://www.pdfsearch.io/img/db59b98300201910c2e78a609662aea9.jpg) | Add to Reading ListSource URL: www.health.gov.nl.caLanguage: English - Date: 2016-02-02 08:19:44
|
---|
3![SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Request for Coverage of Novel Oral Anticoagulant (NOAC) for Atrial Fibrillation (AF) Pharmaceutical Services Department o SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Request for Coverage of Novel Oral Anticoagulant (NOAC) for Atrial Fibrillation (AF) Pharmaceutical Services Department o](https://www.pdfsearch.io/img/1ee73f575cd73f1442cec526307829a2.jpg) | Add to Reading ListSource URL: www.health.gov.nl.caLanguage: English - Date: 2015-06-23 07:06:40
|
---|
4![SPECIAL AUTHORIZATION REQUEST Dabigatran(Pradaxa®), Rivaroxaban(Xarelto®), Apixaban(Eliquis®) Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 SECTION 1 – SPECIAL AUTHORIZATION REQUEST Dabigatran(Pradaxa®), Rivaroxaban(Xarelto®), Apixaban(Eliquis®) Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 SECTION 1 –](https://www.pdfsearch.io/img/9608375912b4eebca970f1e839d433f2.jpg) | Add to Reading ListSource URL: www.gov.pe.caLanguage: English - Date: 2015-04-28 07:57:44
|
---|
5![DecemberSTROKE PREVENTION IN ATRIAL FIBRILLATION: ROLE OF THE NEWER ORAL ANTICOAGULANTS DecemberSTROKE PREVENTION IN ATRIAL FIBRILLATION: ROLE OF THE NEWER ORAL ANTICOAGULANTS](https://www.pdfsearch.io/img/d56c940d4b2b4a542ac04fceedb547d7.jpg) | Add to Reading ListSource URL: www.medicalpharmacies.comLanguage: English - Date: 2014-12-05 13:08:19
|
---|
6![Safety Alert Novel Oral Anticoagulants (NOACs) Issue Apixaban (Eliquis®), dabigatran (Pradaxa®) and rivaroxaban (Xarelto®) are anticoagulants licensed in varying doses in adults for prevention and treatment of venous Safety Alert Novel Oral Anticoagulants (NOACs) Issue Apixaban (Eliquis®), dabigatran (Pradaxa®) and rivaroxaban (Xarelto®) are anticoagulants licensed in varying doses in adults for prevention and treatment of venous](https://www.pdfsearch.io/img/68b4d18407fe7d2cd6bce591a04eeb5d.jpg) | Add to Reading ListSource URL: imsn.ieLanguage: English - Date: 2015-05-07 16:55:49
|
---|
7![NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Atrial Fibrillation NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Atrial Fibrillation](https://www.pdfsearch.io/img/56d0d63dab34e6efbf6ee86707b64926.jpg) | Add to Reading ListSource URL: www.nice.org.ukLanguage: English - Date: 2014-07-30 06:27:48
|
---|
8![](https://www.pdfsearch.io/img/ea95a7d185a52cd23b43aadcb380c6e1.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2014-10-01 21:56:23
|
---|
9![](https://www.pdfsearch.io/img/1c61a333ce0058d7142c2f0c6190437d.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2014-10-01 21:56:22
|
---|
10![Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that](https://www.pdfsearch.io/img/0c30c939059284f9392b37b1e8db2a38.jpg) | Add to Reading ListSource URL: www.scottishmedicines.org.ukLanguage: English |
---|